Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1444, 2004-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inpharma, Vol. 1, Iss. 1499, 2005-01 ,pp. :
Access to resources
Recommend
Positive opinions from the CPMP
Inpharma, Vol. 1, Iss. 1431, 2004-01 ,pp. :
Ambrisentan receives positive opinion for approval in the EU.
Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. :
CHMP opinions on safety variations
Reactions Weekly, Vol. 1, Iss. 1391, 2012-01 ,pp. :